---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294873034.md"
description: "LeMaitre Vascular shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY2026 GAAP EPS and FT2026 sales guidance."
datetime: "2026-08-04T20:56:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294873034.md)
  - [en](https://longbridge.com/en/news/294873034.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294873034.md)
generator: "portal-rs"
---

# 

LeMaitre Vascular shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY2026 GAAP EPS and FT2026 sales guidance.

### Related Stocks

- [LMAT.US](https://longbridge.com/en/quote/LMAT.US.md)

## Related News & Research

- [LeMaitre Vascular Stock In Focus After Updated Guidance And Dividend](https://longbridge.com/en/news/304574279.md)
- [LeMaitre Vascular (LMAT) Stock Could Be 16% Overvalued After Q3 Earnings](https://longbridge.com/en/news/304740161.md)
- [488,932 LeMaitre Vascular, Inc. $LMAT Shares Sold by Conestoga Capital Advisors LLC](https://longbridge.com/en/news/304421928.md)
- [LMAT: Q3 growth and FY guidance remain strong as B. Braun assets expand the vascular portfolio](https://longbridge.com/en/news/304338366.md)
- [LeMaitre Vascular CFO Presents at Three Upcoming Investor Conferences](https://longbridge.com/en/news/304689765.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**